While the participants took study treatment, they visited their study site 17 times. This part of the study lasted 10 weeks. During this time, the participants:
- Took cotadutide or the placebo every day, either by getting 1 injection from the study doctors or by giving themselves 1 injection at home
- Stayed overnight at their study site for several of their study visits
- Kept a diary of their symptoms and wore their CGM device

After the participants took study treatment, they visited their study site 1 time about 4 weeks after their last dose.

What were the results of this study?
This is a summary of the main results from this study overall. The results each participant had might be different and are not in this summary.

Researchers look at the results of many studies to decide which treatments work best and are safest. Other studies may provide new information or different results. Always talk to a doctor before making any treatment changes.

The websites listed at the end of this summary may have a full report of the study results.

What signs and symptoms did the participants have during the study?
To answer this question, the study doctors did tests and measurements throughout the study.

The study doctors:
- Did physical exams
- Tested the participants' blood and urine samples
- Checked the participant's heart health using ECGs

Overall, the researchers found that the participants did have some changes in their heart health during the study. The participants who took cotadutide had a slightly faster heart rate and lower blood pressure than the participants who took the placebo.